Bright Minds Biosciences DRUG
NASDAQ DRUG
$66.83 -1.19 (-1.75%)
As of: Sep 4, 2026 · 1:34 PM EDT

Bright Minds Biosciences (DRUG) EPS (Diluted) (2023 - 2026)

Analysis

Bright Minds Biosciences (DRUG) EPS (Diluted) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 12.23
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn 7.15
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.08 Bn 44.08 Bn - -3.06
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.44 Bn 27.60 Bn - 0.15
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -0.06
10 Bright Minds Biosciences 458.56 Mn 236.02 Mn - -0.87
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.87
Mar 31, 2026 -2.22
Dec 31, 2025 -1.39
Sep 30, 2025 -2.27
Jun 30, 2025 0.96
Mar 31, 2025 0.54
Dec 31, 2024 0.01
Sep 30, 2024 -0.48
Jun 30, 2024 0.04
Mar 31, 2024 0.34
Dec 31, 2023 -0.33
Sep 30, 2023 -1.48
Jun 30, 2023 -0.44